NLS Pharmaceutics (NLSP) announced that its CEO Alex Zwyer, has issued a letter to shareholders, which read in part, “Over ...

Findings published in Brain Sciences showed missed doses and potential for injury when waking to take a second dose among the key challenges ...

ZURICH, SWITZERLAND / ACCESSWIRE / December 11, 2024 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP)(Nasdaq:NLSPW) ("NLS" or the ...

Perceived social support was significantly lower among individuals with idiopathic hypersomnia or narcolepsy type 2 compared with narcolepsy type 1.

Axsome's AXS-12 reduces narcolepsy symptoms, positioning the company for success. Find out why AXSM stock is a buy with ...

By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, e-commerce, Drug Stores and Others) & Region for 2024 to ...

Modafinil, a medication previously used for managing narcolepsy, has also been shown ... It’s thought that these cognitive symptoms are caused by an inflammatory cytokine release that leads ...

I learned the key symptoms of narcolepsy are sleep hallucinations, sleep paralysis and excessive daytime sleepiness. Disrupted sleep at night is also a symptom, which is why I would wake up six to ...

In the second part of the study, investigators used the Narcolepsy Symptom Assessment Questionnaire (NSAQ) to show that patients who were taken off AXS-12 experienced a worsening of their symptoms ...

"Clinical evidence continues to support AXS-12 as a novel treatment option for narcolepsy that has the potential to rapidly ...

Getting familiar with end-of-life symptoms in older adults can help you understand what your loved one may be experiencing, and promote a smooth transition for everyone. Share on Pinterest izusek ...